Cargando…
Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical Trials
Decreasing the risk of lung cancer, or preventing its development in high-risk individuals, would have a huge impact on public health. The most effective means to decrease lung cancer incidence is to eliminate exposure to carcinogens. However, with recent advances in the understanding of pulmonary c...
Autores principales: | Greenberg, Alissa K., Tsay, Jun-Chieh, Tchou-Wong, Kam-Meng, Jorgensen, Anna, Rom, William N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730305/ https://www.ncbi.nlm.nih.gov/pubmed/24216701 http://dx.doi.org/10.3390/cancers5010131 |
Ejemplares similares
-
Molecular Characterization of the Peripheral Airway Field of Cancerization in Lung Adenocarcinoma
por: Tsay, Jun-Chieh J., et al.
Publicado: (2015) -
NF-kappaB in Lung Tumorigenesis
por: Cai, Zhenjian, et al.
Publicado: (2011) -
CT Scan Screening for Lung Cancer: Risk Factors for Nodules and Malignancy in a High-Risk Urban Cohort
por: Greenberg, Alissa K., et al.
Publicado: (2012) -
Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
por: Kim, Connie E., et al.
Publicado: (2011) -
Dimebon disappointment
por: Jones, Roy W
Publicado: (2010)